Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants

被引:0
作者
Nicole Bosshard
Astrid Zbinden
Klara Kristin Eriksson
Frauke Förger
机构
[1] University Hospital–University of Bern,Department of Rheumatology and Immunology
来源
Rheumatology and Therapy | 2021年 / 8卷
关键词
Lactation; Rituximab; Canakinumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1043 / 1048
页数:5
相关论文
共 58 条
[1]  
Victora CG(2016)Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect Lancet 387 475-490
[2]  
Bahl R(2016)The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation Ann Rheum Dis 75 795-810
[3]  
Barros AJ(2020)2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases Arthritis Care Res 72 461-488
[4]  
Gotestam Skorpen C(2019)Balancing the use of medications while maintaining breastfeeding Clin Perinatol 46 367-382
[5]  
Hoeltzenbein M(1997)Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells Immunology 92 69-74
[6]  
Tincani A(2018)Antibody profile of colostrum and the effect of processing in human milk banks: implications in immunoregulatory properties J Hum Lactation 34 137-147
[7]  
Sammaritano LR(2011)Perspectives on immunoglobulins in colostrum and milk Nutrients 3 442-474
[8]  
Bermas BL(2017)Low level of rituximab in human breast milk in a patient treated during lactation Rheumatology 56 1047-1048
[9]  
Chakravarty EE(2020)Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions Neurol Neuroimmunol Neuroinflamm 7 1-704
[10]  
Datta P(2018)Exposure concentrations of infants breastfed by women receiving biologic therapies for inflammatory bowel diseases and effects of breastfeeding on infections and development Gastroenterology 155 696-1896